Doctor profile · Federal record

Dr. Michelle Boniscavage

Family Nurse Practitioner (CMS: Nurse Practitioner) · Wyomissing, PA

  • NPI 1427786581
  • Accepts Medicare
  • MIPS 81.8 / 100 · 2023
  • 4 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2650 Westview Dr. #H
Wyomissing, PA 196101187
(610) 750-9426
fax (484) 282-7430
Mailing address
8 Brookhill Square South
Sugarloaf, PA 182491010

Credentials & registration

NPPES · NUCC
NPI registered
August 2022 — 4 yrs on file
Year of graduation
2022 — 4 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State license (1)
Pennsylvania #SP026034

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1427786581. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
335
Distinct HCPCS
10
Medicare allowed
$20,034
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 87 19 $5
17110 Destruction of skin growth, 1-14 growths 43 26 $89
17000 Destruction of precancer skin growth, 1 growth 39 26 $43
99214 Established patient office or other outpatient visit, 30-39 minutes 31 18 $104
11102 Biopsy of related skin growth, first growth 29 28 $78
99202 New patient office or other outpatient visit, 15-29 minutes 23 23 $59
99204 New patient office or other outpatient visit, 45-59 minutes 23 23 $135
99213 Established patient office or other outpatient visit, 20-29 minutes 23 23 $73
99212 Established patient office or other outpatient visit, 10-19 minutes 21 17 $46
99203 New patient office or other outpatient visit, 30-44 minutes 16 16 $91

In context: peer comparison

Among 9 peers in Wyomissing Family Nurse Practitioner, average services per provider: 51. This provider delivers 6.6× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,924
Transactions
117
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Ucb, INC. 24 $331.87
Abbvie INC. 18 $305.47
E.R. Squibb & Sons, L.L.C. 17 $262.15
Janssen Biotech, INC. 5 $230.62
Dermavant Sciences, INC. 19 $143.34
Novartis Pharmaceuticals Corporation 10 $135.12
Lilly USA, LLC 5 $97.20
Incyte Corporation 5 $97.02
Amgen INC. 4 $94.62
Regeneron Healthcare Solutions, INC. 4 $85.48
Pfizer INC. 2 $44.80
Revance Therapeutics, INC. 1 $26.54
Boehringer Ingelheim Pharmaceuticals, INC. 1 $20.79
Sun Pharmaceutical Industries INC. 1 $20.07
Verrica Pharmaceuticals INC. 1 $15.63

By nature of payment

Food and Beverage
$1,924

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
485
Patients
206
Total drug cost
$21,171
Drug Type Claims Patients Total cost
Clobetasol Propionate Generic 123 52 $9,013
Ketoconazole Generic 95 37 $2,431
Triamcinolone Acetonide Generic 58 37 $1,138
Clindamycin Phosphate Generic 44 21 $2,875
Mometasone Furoate Generic 43 22 $1,333
Metronidazole Generic 24 0 $1,537
Hydrocortisone Generic 19 13 $233
Mupirocin Generic 19 13 $158
Doxycycline Hyclate Generic 13 11 $254
Tretinoin Generic 13 0 $945

Frequently asked questions

Auto-generated from federal data
What is Dr. Michelle Boniscavage's medical specialty?
Dr. Michelle Boniscavage practices Family Nurse Practitioner in Wyomissing, PA.
Where does Dr. Michelle Boniscavage practice?
Dr. Michelle Boniscavage practices at 2650 Westview Dr. #H, Wyomissing, PA 196101187. Office phone: 6107509426.
What is Dr. Michelle Boniscavage's NPI?
Dr. Michelle Boniscavage's National Provider Identifier (NPI) is 1427786581, issued by NPPES.
Does Dr. Michelle Boniscavage accept Medicare assignment?
Yes. Dr. Michelle Boniscavage accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michelle Boniscavage commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of skin growth, 1-14 growths (HCPCS 17110); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.